All In Biotech

Drug Trial Radar · NCT07920887

A Study of Bimagrumab in Participants With HFpEF

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Comparing the Efficacy and Safety of Bimagrumab Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction (ACTIVATE-HFpEF)

Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 540 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

540

Planned (sponsor's estimate)

Start

Nov 2026

Primary completion

Jul 2029

Study completion Nov 2029

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Nov 6, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will look at how bimagrumab affects adults who have a type of heart failure called HFpEF (heart failure with preserved ejection fraction), where the heart pumps normally but does not fill with blood as well as it should. Participation in the study will last about 76 weeks.

Conditions

  • Heart Failure, Diastolic
  • Diastolic Heart Failure
  • Heart Failure, Normal Ejection Fraction
  • Heart Failure, Preserved Ejection Fraction

Interventions

  • BimagrumabDrug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in the Kansas City Cardiomyopathy Questionnaire-Clinical Summary Score (KCCQ-CSS)Time frame: Baseline, Week 52

Locations

9 sites in 4 countries. Site status is shown where the registry gives one.

  • InvivoCure LLC

    Van Nuys, California

  • Amavita Research Services, LLC

    North Miami Beach, Florida

  • Dharma PA d/b/a Southwest Family Medicine Associates

    Dallas, Texas

  • Semmelweis Egyetem - Varosmajori Sziv es Ergyogyaszati Klinika

    Budapest, Hungary

  • Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Sant' Anna e San Sebastiano di Caserta

    Caserta, Italy

  • A.O. Ordine Mauriziano di Torino

    Torino, Italy

  • Krakowski Szpital Specjalistyczny im. sw. Jana Pawla II

    Krakow, Poland

  • Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu

    Wroclaw, Poland

  • 4 Wojskowy Szpital Kliniczny z Poliklinika Samodzielny Publiczny ZOZ we Wroclawiu

    Wroclaw, Poland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.